Denali Therapeutics Inc. - COM (DNLI)

Q1 2024 Portfolio Holders as of 3/31/2024

Type / Class
Equity / COM
Number of holders
201
Total Shares
116 M
Shares change
+6.22 M
Total reported value, excl. options
$2.38 B
Value change
+$123 M
Put/Call ratio
0.98
Number of buys
103
Number of sells
-100
Price
$20.52
CUSIP
24823R105
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.